Predictive Markers of the Course of Covid-19 Based on Biomarker Serum Amyloid A (SAA) and Genetic Markers
Clinical trial NCT07120269 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07120269
- Sponsor
- Thomayer University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-10
- Primary completion
- 2023-06-26
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.